Free Trial

Soltis Investment Advisors LLC Purchases Shares of 3,486 The Clorox Company (NYSE:CLX)

Clorox logo with Consumer Staples background

Soltis Investment Advisors LLC bought a new position in shares of The Clorox Company (NYSE:CLX - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,486 shares of the company's stock, valued at approximately $566,000.

Several other hedge funds have also made changes to their positions in the business. Brooklyn Investment Group lifted its position in Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC acquired a new stake in Clorox in the third quarter valued at about $27,000. Continuum Advisory LLC lifted its position in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company's stock valued at $30,000 after purchasing an additional 138 shares during the period. Carolina Wealth Advisors LLC acquired a new stake in Clorox in the third quarter valued at about $48,000. Finally, Friedenthal Financial acquired a new stake in Clorox in the third quarter valued at about $49,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Analysts Set New Price Targets

CLX has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. raised their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Evercore ISI increased their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. StockNews.com cut shares of Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Barclays increased their target price on shares of Clorox from $130.00 to $140.00 and gave the company an "underweight" rating in a report on Wednesday, February 5th. Finally, TD Cowen raised shares of Clorox from a "sell" rating to a "hold" rating and increased their target price for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Four equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $158.21.

Get Our Latest Stock Analysis on CLX

Clorox Price Performance

Shares of CLX traded down $2.86 during mid-day trading on Friday, reaching $147.91. 1,318,065 shares of the company's stock were exchanged, compared to its average volume of 1,333,562. The company has a quick ratio of 0.62, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The company has a 50-day simple moving average of $159.55 and a two-hundred day simple moving average of $159.13. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a market cap of $18.31 billion, a price-to-earnings ratio of 40.41, a PEG ratio of 2.52 and a beta of 0.42.

Clorox (NYSE:CLX - Get Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the company earned $2.16 EPS. On average, sell-side analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a yield of 3.30%. Clorox's dividend payout ratio (DPR) is currently 133.33%.

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines